BRIEF-Entero Therapeutics Announces Proposed Reverse Merger With Journey Therapeutics

Reuters11-13

Nov 13 (Reuters) - Entero Therapeutics Inc :

* ENTERO THERAPEUTICS ANNOUNCES PROPOSED REVERSE MERGER WITH JOURNEY THERAPEUTICS, A CLINICAL STAGE, FIRST-IN-CLASS, NEXT-GENERATION ADC-RIVALLING NANO-IMMUNOCONJUGATES BIOPHARMACEUTICAL COMPANY

* ENTERO THERAPEUTICS INC - JOURNEY SHAREHOLDERS TO ACQUIRE 99% OF ENTERO EQUITY

* ENTERO THERAPEUTICS INC - COMBINED COMPANY TO OPERATE AS JOURNEY THERAPEUTICS AND APPLY FOR NASDAQ LISTING

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483007585?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-13 21:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483007585","market":"us","top_or_hot":-1,"title":"BRIEF-Entero Therapeutics Announces Proposed Reverse Merger With Journey Therapeutics","media":"Reuters","content":"<html><body><p>Nov 13 (Reuters) - Entero <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc   :</p><p>   * ENTERO THERAPEUTICS ANNOUNCES PROPOSED REVERSE MERGER WITH JOURNEY THERAPEUTICS, A CLINICAL STAGE, FIRST-IN-CLASS, NEXT-GENERATION ADC-RIVALLING NANO-IMMUNOCONJUGATES BIOPHARMACEUTICAL COMPANY</p><p>   * ENTERO THERAPEUTICS INC - JOURNEY SHAREHOLDERS TO ACQUIRE 99% OF ENTERO EQUITY</p><p>   * ENTERO THERAPEUTICS INC - COMBINED COMPANY TO OPERATE AS JOURNEY THERAPEUTICS AND APPLY FOR NASDAQ LISTING</p><p>Source text:   Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Entero Therapeutics Announces Proposed Reverse Merger With Journey Therapeutics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Entero Therapeutics Announces Proposed Reverse Merger With Journey Therapeutics\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-13 21:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 13 (Reuters) - Entero Therapeutics Inc   :   * ENTERO THERAPEUTICS ANNOUNCES PROPOSED REVERSE MERGER WITH JOURNEY THERAPEUTICS, A CLINICAL STAGE, FIRST-IN-CLASS, NEXT-GENERATION ADC-RIVALLING NANO...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2483007585","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483007585","pubTimestamp":1731503468,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 13  - Entero Therapeutics Inc   :   * ENTERO THERAPEUTICS ANNOUNCES PROPOSED REVERSE MERGER WITH JOURNEY THERAPEUTICS, A CLINICAL STAGE, FIRST-IN-CLASS, NEXT-GENERATION ADC-RIVALLING NANO-IMMUNOCONJUGATES BIOPHARMACEUTICAL COMPANY   * ENTERO THERAPEUTICS INC - JOURNEY SHAREHOLDERS TO ACQUIRE 99% OF ENTERO EQUITY   * ENTERO THERAPEUTICS INC - COMBINED COMPANY TO OPERATE AS JOURNEY THERAPEUTICS AND APPLY FOR NASDAQ LISTINGSource text:   Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","ENTO":"Entero Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"简介-Entero Therapeutics宣布拟与Journey Therapeutics进行反向合并","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"ENTO":0.9},"content_text":"Nov 13 (Reuters) - Entero Therapeutics Inc   :   * ENTERO THERAPEUTICS ANNOUNCES PROPOSED REVERSE MERGER WITH JOURNEY THERAPEUTICS, A CLINICAL STAGE, FIRST-IN-CLASS, NEXT-GENERATION ADC-RIVALLING NANO-IMMUNOCONJUGATES BIOPHARMACEUTICAL COMPANY   * ENTERO THERAPEUTICS INC - JOURNEY SHAREHOLDERS TO ACQUIRE 99% OF ENTERO EQUITY   * ENTERO THERAPEUTICS INC - COMBINED COMPANY TO OPERATE AS JOURNEY THERAPEUTICS AND APPLY FOR NASDAQ LISTINGSource text:   Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483007585"}